Science for Life.
ProPhase Labs develops and markets clinically proven remedies including the highly effective Cold-EEZE® and Kids-EEZE® product lines. Our ongoing objective is to deliver long-term value by providing exceptional new products that address the health care and quality of life concerns of the broadest market segments.
April 07, 2016 - ProPhase Labs (Nasdaq: PRPH) to Ring The Nasdaq Stock Market Closing Bell
March 29, 2016 - ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015
March 25, 2016 - ProPhase Labs to Release Fourth Quarter/Year End Results on Tuesday, March 29th
The Cold-EEZE® family of lozenges are clinically proven to reduce the duration of the common cold.